Opportunistic Screening For Atrial Fibrillation In Primary Care – A Clinical And Cost-Effectiveness Analysis

Opportunistic Screening ◽

Cost-effectiveness analysis of dabigatran versus rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation using real-world evidence in elderly US Medicare beneficiaries

Current Medical Research and Opinion ◽

10.1080/03007995.2017.1375470 ◽

2017 ◽

Vol 34 (1) ◽

pp. 55-63 ◽

Cited By ~ 3

Author(s):

Siyang Peng ◽

Kristen A. Deger ◽

Anastasia Ustyugova ◽

Pranav Gandhi ◽

Nan Qiao ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Real World ◽

Stroke Prevention ◽

Medicare Beneficiaries ◽

Effectiveness Analysis ◽

Real World Evidence

PCV114 FEASIBILITY OF USING REAL WORLD EVIDENCE TO INFORM DECISIONS ON CONDUCTING A COST EFFECTIVENESS ANALYSIS: AN EXAMPLE OF STROKE RISK REDUCTION THERAPIES IN ATRIAL FIBRILLATION

Value in Health ◽

10.1016/j.jval.2019.09.838 ◽

2019 ◽

Vol 22 ◽

pp. S563

Author(s):

O. Saunders ◽

R.L. Akehurst ◽

Y. Zhong ◽

S.L. Amorosi ◽

M. Gavaghan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Risk Reduction ◽

Real World ◽

Stroke Risk ◽

Effectiveness Analysis ◽

Real World Evidence

Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of Bleeding

PharmacoEconomics ◽

10.1007/s40273-018-0741-3 ◽

2018 ◽

Vol 37 (2) ◽

pp. 279-289 ◽

Cited By ~ 4

Author(s):

Thananan Rattanachotphanit ◽

Chulaporn Limwattananon ◽

Onanong Waleekhachonloet ◽

Phumtham Limwattananon ◽

Kittisak Sawanyawisuth

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

High Risk ◽

Stroke Prevention ◽

Oral Anticoagulants ◽

Risk Of Bleeding ◽

Effectiveness Analysis ◽

Direct Acting ◽

Direct Acting Oral Anticoagulants

New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

Italian Journal of Medicine ◽

10.4081/itjm.2013.s8.65 ◽

2013 ◽

Vol 7 (8S) ◽

pp. 65

Author(s):

Mauro Silingardi

Keyword(s):

Atrial Fibrillation ◽

Economic Evaluation ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Anticoagulant Drugs

PCV54 Cost-Effectiveness Analysis of Dabigatran Compared to Warfarin for Stroke Prevention in Atrial Fibrillation in a Medicare Population

Value in Health ◽

10.1016/j.jval.2012.03.657 ◽

2012 ◽

Vol 15 (4) ◽

pp. A121

Author(s):

M.A. Ward ◽

A.K. Biddle

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Stroke Prevention ◽

Medicare Population ◽

PCV5 Cost-Effectiveness Analysis of Apixaban in Treatment of Atrial Fibrillation: A Systematic Review

Value in Health Regional Issues ◽

10.1016/j.vhri.2020.07.023 ◽

2020 ◽

Vol 22 ◽

pp. S26-S27

Author(s):

D. Tran ◽

C. Nguyen ◽

T. Nguyen

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Cost Effectiveness ◽

Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation—results for Canada, Italy, Sweden and Switzerland

The European Journal of Health Economics ◽

10.1007/s10198-012-0391-x ◽

2012 ◽

Vol 14 (3) ◽

pp. 481-493 ◽

Cited By ~ 2

Author(s):

Jonas Nilsson ◽

Örjan Åkerborg ◽

Gaëlle Bégo-Le Bagousse ◽

Mårten Rosenquist ◽

Peter Lindgren

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

PCV50 COST-EFFECTIVENESS ANALYSIS COMPARING DABIGATRAN AND ADJUSTED-DOSE WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION

Value in Health ◽

10.1016/j.jval.2011.02.237 ◽

2011 ◽

Vol 14 (3) ◽

pp. A41

Author(s):

Y. Zhao ◽

L. Lim ◽

C.I. Coleman

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Stroke Prevention ◽

Effectiveness Analysis ◽

Dose Warfarin ◽

Adjusted Dose

A224 COST-EFFECTIVENESS ANALYSIS OF FECAL CALPROTECTIN USED IN PRIMARY CARE IN THE DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE

Journal of the Canadian Association of Gastroenterology ◽

10.1093/jcag/gwy009.224 ◽

2018 ◽

Vol 1 (suppl_2) ◽

pp. 332-332

Author(s):

M Chavannes ◽

C Wong ◽

T Mohammadi ◽

W Zhang ◽

G Rosenfeld

Keyword(s):

Primary Care ◽

Inflammatory Bowel Disease ◽

Cost Effectiveness ◽

Bowel Disease ◽

Fecal Calprotectin ◽

Effectiveness Analysis ◽

Inflammatory Bowel

PCV40 COST-EFFECTIVENESS ANALYSIS OF THE INSERTABLE CARDIAC MONITOR FOR DETECTING RECURRENT ATRIAL FIBRILLATION (AF) FOLLOWING RADIOFREQUENCY CATHETER ABLATION (RCA): A CANADIAN PERSPECTIVE

Value in Health ◽

10.1016/s1098-3015(10)73802-x ◽

2009 ◽

Vol 12 (3) ◽

pp. A148

Author(s):

H Sadri ◽

S Tsintzos ◽

R Yee ◽

A Skanes ◽

L Gula

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Catheter Ablation ◽

Radiofrequency Catheter Ablation ◽

Cardiac Monitor ◽

Effectiveness Analysis ◽

Recurrent Atrial Fibrillation ◽

Canadian Perspective ◽

Insertable Cardiac Monitor